BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8136100)

  • 1. Antihypertensive effects of oral calcium supplementation may be mediated through the potent vasodilator CGRP.
    Wimalawansa SJ
    Am J Hypertens; 1993 Dec; 6(12):996-1002. PubMed ID: 8136100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the antihypertensive effects of dietary calcium and role of calcitonin gene related peptide in hypertension.
    Wimalawansa SJ; Supowit SC; DiPette DJ
    Can J Physiol Pharmacol; 1995 Jul; 73(7):981-5. PubMed ID: 8846440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PTH, PTHrP, and CGRP in hypertension research].
    Hosoi M; Nishizawa Y; Morii H
    Nihon Rinsho; 1997 Aug; 55(8):1950-7. PubMed ID: 9284406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension.
    Zoccali C; Mallamaci F; Parlongo S
    J Hypertens; 1994 Nov; 12(11):1249-53. PubMed ID: 7868872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of benidipine on plasma level of calcitonin gene-related peptide in essential hypertension].
    Jin WY; Sun W; Zhang YZ; Li HY; Chen MZ; Guo JX
    Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):747-9. PubMed ID: 15631826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats.
    Li D; Peng J; Xin HY; Luo D; Zhang YS; Zhou Z; Jiang DJ; Deng HW; Li YJ
    Peptides; 2008 Oct; 29(10):1781-8. PubMed ID: 18625276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-regulating hormones in hypertension: vascular actions.
    Bukoski RD; Kremer D
    Am J Clin Nutr; 1991 Jul; 54(1 Suppl):220S-226S. PubMed ID: 2053566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin gene-related peptide in the pathogenesis and treatment of hypertension.
    Tang JA; Xu D; Yuan QX; Meng ZH; Cheng FR; Chen MZ; Liu GZ; Liu LS; Zhang ZK
    Chin Med J (Engl); 1989 Dec; 102(12):897-901. PubMed ID: 2517732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal serum levels of calcitonin gene-related peptide (CGRP) in mild to moderate essential hypertension.
    Schifter S; Krusell LR; Sehested J
    Am J Hypertens; 1991 Jul; 4(7 Pt 1):565-9. PubMed ID: 1873010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of an oral calcium supplement in the treatment of slight-to- moderate essential arterial hypertension].
    Oliván Martínez J; Pérez Cano R; Miranda García MJ; Montoya García MJ; Moruno García R; Cuenca López L; Garrido Peralta M
    An Med Interna; 1989 Apr; 6(4):192-6. PubMed ID: 2491521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human adrenomedullin 13-52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster.
    Hall JM; Siney L; Lippton H; Hyman A; Kang-Chang J; Brain SD
    Br J Pharmacol; 1995 Feb; 114(3):592-7. PubMed ID: 7735685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating perivascular dilatory neuropeptides in hypertension.
    Edvinsson L; Ekman R; Thulin T
    J Hypertens Suppl; 1989 Dec; 7(6):S194-5. PubMed ID: 2483731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin gene-related peptide and hypertension.
    Deng PY; Li YJ
    Peptides; 2005 Sep; 26(9):1676-85. PubMed ID: 16112410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients.
    Calò LA; Dal Maso L; Pagnin E; Ravarotto V; Facco M; Boscaro E; Maiolino G; Pessina AC; Rossi GP
    J Hypertens; 2014 Jan; 32(1):193-9. PubMed ID: 24309489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ALDH2 Glu504Lys polymorphism on nitroglycerin response in chronic heart failure and involvement of Calcitonin Gene Related Peptide (CGRP).
    Peng LM; Chen XP; Sun J; Guo YJ; Li L; Mo L; Xie W; Li YJ; Yang TL; Li CC
    Int J Clin Pharmacol Ther; 2012 Oct; 50(10):701-11. PubMed ID: 22909898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plethysmographic evaluation of the vascular effects of human calcitonin gene-related peptide in man.
    Gennari C; Nami R; Pecchi S; De Franco V; Panza F; Pavese G
    Angiology; 1991 Jun; 42(6):462-7. PubMed ID: 2042794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma calcitonin gene-related peptide (CGRP) level in patients with essential hypertension].
    Shi XY; Yang Y; Zhao YT
    Zhonghua Nei Ke Za Zhi; 1990 Oct; 29(10):616-8, 639. PubMed ID: 2150797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone and calcium. A relationship in hypertension.
    Zachariah PK; Schwartz GL; Strong CG; Ritter SG
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):79S-82S. PubMed ID: 3415813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of plasma adrenomedullin and calcitonin gene-related peptide concentration in patients with Type 2 diabetes mellitus who are treated for cardiovascular risk factors.
    Charvat J; Svab P; Havlin J; Bilek R; Zamrazil V
    Neuro Endocrinol Lett; 2014; 35(2):154-8. PubMed ID: 24878981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin gene-related peptide in hepatorenal syndrome. A possible mediator of peripheral vasodilation?
    Gupta S; Morgan TR; Gordan GS
    J Clin Gastroenterol; 1992 Mar; 14(2):122-6. PubMed ID: 1532610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.